Attached Carole Ho - 23 Aug 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
23 Aug 2021
Net transactions value
-$300,454
Form type
4
Filing time
25 Aug 2021, 18:26:49 UTC
Previous filing
23 Aug 2021
Next filing
08 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale $300,454 -6,143 -3.7% $48.91 158,630 23 Aug 2021 See footnote F1, F2
holding DNLI Common Stock 77,792 23 Aug 2021 Direct F3
holding DNLI Common Stock 25,000 23 Aug 2021 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 Includes 75,906 restricted stock units.
F4 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.